Dataset from A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Dose-Ranging Phase 2 Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of ALD403 Administered Intravenously in Patients With Chronic Migraine
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00008252
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess ALD403 in the prevention of migraine headache in
chronic migraineurs.
创建时间：
2024-11-26
